Status:

RECRUITING

High Intensity Laser Therapy (HILT) on Myofascial Trigger Points.

Lead Sponsor:

Quiropraxia y Equilibrio

Conditions:

Myofascial Trigger Point Pain (MTrP)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the study is to evaluate the effects of HILT on cervical flexibility and pain reduction in myofascial trigger points. The research will be carried out in the Physiotherapy laboratory of And...

Detailed Description

Material and Methods Type of study: Experimental, randomized clinical trial (RCT). 1\. Study population. For the study, students and workers of Andrés Bello University will be considered participan...

Eligibility Criteria

Inclusion

  • Participants over 18 years of age.
  • Officials and students of the Casona las Condes Campus of the Andrés Bello University.
  • Presence of myofascial trigger points in the shortened upper trapezius muscle evaluated (expert consensus establishing criteria for the diagnosis of MTrPs, Delphi study).25

Exclusion

  • Musculoskeletal problems or pathologies of the neck or shoulders in the last 3 months (fractures, sprains, tendinopathies, dislocations, or muscle tears).
  • Presence of osteosynthesis materials near shoulders, neck, or surrounding areas.
  • Presence of wounds or skin changes in the shoulder and/or neck region (such as psoriasis, scars, or burns).
  • Use of analgesic, anti-inflammatory, or muscle relaxant medications for permanent use.
  • Neurological changes such as paresthesia, loss of sensitivity (partial or complete), decreased strength, and color changes in the neck, arms, forearms, or hands.
  • Diagnosed photosensitivity.
  • Presence of solar urticaria or adverse reactions to sunlight.
  • Presence of the following conditions: dermatomyositis, systemic lupus erythematosus, hepatic porphyria, cutaneous carcinoid syndrome or pellagra
  • Cancer or tumors of any type diagnosed.
  • Epilepsy.

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04445545

Start Date

May 1 2025

End Date

September 1 2025

Last Update

August 7 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Universidad Andrés Bello

Santiago, Las Condes, Chile, 7591538

2

Universidad Andrés Bello

Santiago, Santiago Metropolitan, Chile, 7591538